Related Experiment Video
Updated: Jun 1, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
An open clinical trial with clozapine in treatment-resistant schizophrenics
A K Agarwal1, M Sharma, S Srivastava
1A.K. AGARWAL, MD., DPM., Professor & Head, K.G.'s Medical College, Lucknow.
Abstract:
In an open trial, drug-resistant schizophrenics were treated with clozapine for sixteen weeks. The patients were rated on BPRS, PANSS, Side effects scale and Global Impression Scale at weeks 0. 9 and 16. A battery of base-line investigations were done, and hemogram was repeated at weekly intervals. Of the total 29 patient included. 25 completed the trial. The patients showed significant improvement on both BPRS and PANSS, although the improvement was more in initial weeks than between 9 and 16 weeks. The most common side effects observed were sedation, hypersalivation and tachycardia. Issues of response of clozapine on negative symptoms and a longer duration of the drug therapy are discussed.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Treatment Resistent Cancers
Drug Therapy
Antianxiety Medications
Treatment Resistant Cancers